2/29
10:45 am
stok
Why Earnings Season Could Be Great for Stoke Therapeutics (STOK) [Yahoo! Finance]
Low
Report
Why Earnings Season Could Be Great for Stoke Therapeutics (STOK) [Yahoo! Finance]
2/26
11:56 am
stok
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy? [Yahoo! Finance]
Medium
Report
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy? [Yahoo! Finance]
2/16
08:11 am
stok
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Medium
Report
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
2/15
11:53 am
stok
Does Stoke Therapeutics, Inc. (STOK) Have the Potential to Rally 284.14% as Wall Street Analysts Expect? [Yahoo! Finance]
Medium
Report
Does Stoke Therapeutics, Inc. (STOK) Have the Potential to Rally 284.14% as Wall Street Analysts Expect? [Yahoo! Finance]
2/15
08:52 am
stok
Stoke Therapeutics, Inc. (STOK) Stock Jumps 25.5%: Will It Continue to Soar? [Yahoo! Finance]
Low
Report
Stoke Therapeutics, Inc. (STOK) Stock Jumps 25.5%: Will It Continue to Soar? [Yahoo! Finance]
2/7
06:13 am
stok
Scion Life Sciences Launches with Oversubscribed $310 Million Fund to Create and Build Exceptional Biotech Companies [Yahoo! Finance]
Medium
Report
Scion Life Sciences Launches with Oversubscribed $310 Million Fund to Create and Build Exceptional Biotech Companies [Yahoo! Finance]
1/17
04:30 pm
stok
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Low
Report
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
1/8
08:08 am
stok
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024 [Yahoo! Finance]
Low
Report
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024 [Yahoo! Finance]
1/8
08:00 am
stok
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
Low
Report
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
1/4
04:38 pm
stok
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Neutral
Report
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/4
04:30 pm
stok
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Neutral
Report
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference